

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of guanylate cyclase activity (GO:0031282) | 7.63660308 |
| 2 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.87046746 |
| 3 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.91380866 |
| 4 | * angiotensin maturation (GO:0002003) | 5.85571167 |
| 5 | intestinal absorption (GO:0050892) | 5.71861521 |
| 6 | intestinal cholesterol absorption (GO:0030299) | 5.32548684 |
| 7 | adhesion of symbiont to host cell (GO:0044650) | 5.05624770 |
| 8 | virion attachment to host cell (GO:0019062) | 5.05624770 |
| 9 | surfactant homeostasis (GO:0043129) | 4.93720901 |
| 10 | regulation of cGMP biosynthetic process (GO:0030826) | 4.83557992 |
| 11 | regulation of bile acid biosynthetic process (GO:0070857) | 4.82709051 |
| 12 | glycosphingolipid catabolic process (GO:0046479) | 4.69037046 |
| 13 | glycolipid catabolic process (GO:0019377) | 4.63140062 |
| 14 | regulation of cellular extravasation (GO:0002691) | 4.60147604 |
| 15 | vitamin A metabolic process (GO:0006776) | 4.57206337 |
| 16 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.49866551 |
| 17 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.48303225 |
| 18 | sexual reproduction (GO:0019953) | 4.36891210 |
| 19 | adhesion of symbiont to host (GO:0044406) | 4.31332555 |
| 20 | renal system process involved in regulation of blood volume (GO:0001977) | 4.14535700 |
| 21 | regulation of vitamin metabolic process (GO:0030656) | 4.03976179 |
| 22 | * regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.03283956 |
| 23 | * regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.03283956 |
| 24 | * endocrine process (GO:0050886) | 4.03283956 |
| 25 | regulation of cGMP metabolic process (GO:0030823) | 4.02650877 |
| 26 | drug catabolic process (GO:0042737) | 3.98499440 |
| 27 | chemical homeostasis within a tissue (GO:0048875) | 3.88501078 |
| 28 | ceramide catabolic process (GO:0046514) | 3.82804351 |
| 29 | * regulation of systemic arterial blood pressure (GO:0003073) | 3.80629669 |
| 30 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.62714872 |
| 31 | sphingolipid catabolic process (GO:0030149) | 3.58284620 |
| 32 | actin filament depolymerization (GO:0030042) | 3.56765695 |
| 33 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.56761672 |
| 34 | urea cycle (GO:0000050) | 3.55677260 |
| 35 | regulation of endothelial cell differentiation (GO:0045601) | 3.54853064 |
| 36 | artery development (GO:0060840) | 3.52458578 |
| 37 | bile acid and bile salt transport (GO:0015721) | 3.50644820 |
| 38 | * peptide hormone processing (GO:0016486) | 3.50593797 |
| 39 | membrane lipid catabolic process (GO:0046466) | 3.49274714 |
| 40 | vitamin transmembrane transport (GO:0035461) | 3.46652433 |
| 41 | vitamin transport (GO:0051180) | 3.41000139 |
| 42 | fat-soluble vitamin metabolic process (GO:0006775) | 3.40939918 |
| 43 | urea metabolic process (GO:0019627) | 3.39816251 |
| 44 | positive regulation of p38MAPK cascade (GO:1900745) | 3.38175028 |
| 45 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.33695468 |
| 46 | homocysteine metabolic process (GO:0050667) | 3.27246638 |
| 47 | organic cation transport (GO:0015695) | 3.26728766 |
| 48 | transepithelial transport (GO:0070633) | 3.26415243 |
| 49 | alkaloid metabolic process (GO:0009820) | 3.25677541 |
| 50 | flavonoid metabolic process (GO:0009812) | 3.25338777 |
| 51 | cGMP-mediated signaling (GO:0019934) | 3.24927005 |
| 52 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.24921847 |
| 53 | drinking behavior (GO:0042756) | 3.22835899 |
| 54 | regulation of p38MAPK cascade (GO:1900744) | 3.22695805 |
| 55 | vitamin D metabolic process (GO:0042359) | 3.18339909 |
| 56 | leukotriene metabolic process (GO:0006691) | 3.18011515 |
| 57 | antimicrobial humoral response (GO:0019730) | 3.17553378 |
| 58 | drug transmembrane transport (GO:0006855) | 3.16981523 |
| 59 | hemidesmosome assembly (GO:0031581) | 3.16821327 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 3.16812707 |
| 61 | vitamin biosynthetic process (GO:0009110) | 3.16070660 |
| 62 | regulation of cholesterol esterification (GO:0010872) | 3.15972207 |
| 63 | antibacterial humoral response (GO:0019731) | 3.13703935 |
| 64 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.13408604 |
| 65 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.13408604 |
| 66 | nitrogen cycle metabolic process (GO:0071941) | 3.13383555 |
| 67 | positive regulation of cGMP metabolic process (GO:0030825) | 3.13053818 |
| 68 | blood vessel maturation (GO:0001955) | 3.11545581 |
| 69 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.09246765 |
| 70 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.08472881 |
| 71 | cellular response to nitric oxide (GO:0071732) | 3.06375741 |
| 72 | glycosylceramide metabolic process (GO:0006677) | 3.04831395 |
| 73 | positive regulation of pseudopodium assembly (GO:0031274) | 3.04822668 |
| 74 | uronic acid metabolic process (GO:0006063) | 3.04166352 |
| 75 | glucuronate metabolic process (GO:0019585) | 3.04166352 |
| 76 | cellular glucuronidation (GO:0052695) | 3.02538655 |
| 77 | modified amino acid transport (GO:0072337) | 3.01431737 |
| 78 | sphingomyelin metabolic process (GO:0006684) | 2.99438320 |
| 79 | renal absorption (GO:0070293) | 2.97764576 |
| 80 | drug transport (GO:0015893) | 2.96117831 |
| 81 | morphogenesis of an endothelium (GO:0003159) | 2.94147112 |
| 82 | endothelial tube morphogenesis (GO:0061154) | 2.94147112 |
| 83 | phenol-containing compound catabolic process (GO:0019336) | 2.93306635 |
| 84 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.93297422 |
| 85 | sperm capacitation (GO:0048240) | 2.91941160 |
| 86 | glycerol metabolic process (GO:0006071) | 2.91059466 |
| 87 | polyol transport (GO:0015791) | 2.89081776 |
| 88 | epithelial cell-cell adhesion (GO:0090136) | 2.88826296 |
| 89 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.88494523 |
| 90 | amino-acid betaine transport (GO:0015838) | 2.87451819 |
| 91 | carnitine transport (GO:0015879) | 2.87451819 |
| 92 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.86764253 |
| 93 | cobalamin metabolic process (GO:0009235) | 2.85400766 |
| 94 | arachidonic acid metabolic process (GO:0019369) | 2.83858867 |
| 95 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.82987577 |
| 96 | transcytosis (GO:0045056) | 2.82782808 |
| 97 | response to phenylpropanoid (GO:0080184) | 2.82515812 |
| 98 | renal filtration (GO:0097205) | 2.80805686 |
| 99 | regulation of vasculogenesis (GO:2001212) | 2.78045898 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.77748173 |
| 101 | apoptotic cell clearance (GO:0043277) | 2.76969013 |
| 102 | arginine metabolic process (GO:0006525) | 2.76616981 |
| 103 | NADH metabolic process (GO:0006734) | 2.76261277 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 2.75842262 |
| 105 | exogenous drug catabolic process (GO:0042738) | 2.75288139 |
| 106 | regulation of pseudopodium assembly (GO:0031272) | 2.75068703 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 2.74890653 |
| 108 | cellular carbohydrate catabolic process (GO:0044275) | 2.74491509 |
| 109 | bile acid metabolic process (GO:0008206) | 2.73232801 |
| 110 | lipoprotein transport (GO:0042953) | 2.72543153 |
| 111 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.72455575 |
| 112 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.71307699 |
| 113 | eosinophil chemotaxis (GO:0048245) | 2.70553997 |
| 114 | oligosaccharide catabolic process (GO:0009313) | 2.69677455 |
| 115 | cellular response to reactive nitrogen species (GO:1902170) | 2.69664262 |
| 116 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.67966762 |
| 117 | lysine catabolic process (GO:0006554) | 2.67435299 |
| 118 | lysine metabolic process (GO:0006553) | 2.67435299 |
| 119 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.66547723 |
| 120 | respiratory tube development (GO:0030323) | 2.66110542 |
| 121 | lipoprotein metabolic process (GO:0042157) | 2.65231158 |
| 122 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.65103916 |
| 123 | quaternary ammonium group transport (GO:0015697) | 2.64503507 |
| 124 | epoxygenase P450 pathway (GO:0019373) | 2.64129549 |
| 125 | skeletal muscle adaptation (GO:0043501) | 2.62640866 |
| 126 | digestive system process (GO:0022600) | 2.62107613 |
| 127 | regulation of cholesterol homeostasis (GO:2000188) | 2.61496753 |
| 128 | protein localization to endosome (GO:0036010) | 2.58606309 |
| 129 | phospholipid efflux (GO:0033700) | 2.58035917 |
| 130 | * regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.57819653 |
| 131 | glucose 6-phosphate metabolic process (GO:0051156) | 2.56375063 |
| 132 | low-density lipoprotein particle clearance (GO:0034383) | 2.54731402 |
| 133 | drug metabolic process (GO:0017144) | 2.53916643 |
| 134 | striated muscle atrophy (GO:0014891) | 2.51998023 |
| 135 | digestion (GO:0007586) | 2.50769048 |
| 136 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.50368827 |
| 137 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48175144 |
| 138 | lymphangiogenesis (GO:0001946) | 2.47575040 |
| 139 | cGMP biosynthetic process (GO:0006182) | 2.44784593 |
| 140 | hypotonic response (GO:0006971) | 2.42432498 |
| 141 | cholesterol efflux (GO:0033344) | 2.41890540 |
| 142 | diacylglycerol metabolic process (GO:0046339) | 2.41412563 |
| 143 | protein targeting to Golgi (GO:0000042) | 2.39845314 |
| 144 | protein-lipid complex assembly (GO:0065005) | 2.37220506 |
| 145 | beta-amyloid metabolic process (GO:0050435) | 2.36262137 |
| 146 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.35008288 |
| 147 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.35007734 |
| 148 | bicarbonate transport (GO:0015701) | 2.34896639 |
| 149 | glomerular filtration (GO:0003094) | 2.34571159 |
| 150 | response to hepatocyte growth factor (GO:0035728) | 2.34564050 |
| 151 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.34564050 |
| 152 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.33870323 |
| 153 | sulfur compound transport (GO:0072348) | 2.33352098 |
| 154 | plasma lipoprotein particle assembly (GO:0034377) | 2.32553506 |
| 155 | protein kinase C signaling (GO:0070528) | 2.31746531 |
| 156 | sperm motility (GO:0030317) | 2.31211216 |
| 157 | response to nitric oxide (GO:0071731) | 2.30817018 |
| 158 | fructose metabolic process (GO:0006000) | 2.30339225 |
| 159 | carnitine transmembrane transport (GO:1902603) | 2.30042944 |
| 160 | sterol homeostasis (GO:0055092) | 2.29857395 |
| 161 | sterol transport (GO:0015918) | 2.28193894 |
| 162 | cholesterol transport (GO:0030301) | 2.28193894 |
| 163 | phosphate ion transmembrane transport (GO:0035435) | 2.28109925 |
| 164 | cholesterol homeostasis (GO:0042632) | 2.27848994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.97951556 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.48765231 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.99232709 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.71183756 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.68647819 |
| 6 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.55421713 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.50175175 |
| 8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.20692425 |
| 9 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.19271360 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16555486 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02014391 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.00308749 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98551882 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 1.96298600 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.94713651 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83836913 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78492542 |
| 18 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.78114897 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77592867 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.72246682 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70351011 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.69295423 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68648711 |
| 24 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.66076731 |
| 25 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.64817417 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.62501578 |
| 27 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.61824011 |
| 28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57963269 |
| 29 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.56945579 |
| 30 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.56629261 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56084599 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54993412 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52966117 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51726167 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50058286 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48898959 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.48563509 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.48563509 |
| 39 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.47174319 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45228943 |
| 41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43549809 |
| 42 | SA1_27219007_Chip-Seq_Bcells_Human | 1.40462089 |
| 43 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38666626 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35481555 |
| 45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35052169 |
| 46 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31495533 |
| 47 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31304577 |
| 48 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31094453 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30630109 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29485843 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28194354 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27919351 |
| 53 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.26948481 |
| 54 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26853637 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26175538 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22240984 |
| 57 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19163814 |
| 58 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18585998 |
| 59 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.18433028 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17760887 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17548212 |
| 62 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17497625 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16794915 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16792506 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15527826 |
| 66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13465992 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.13200320 |
| 68 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11426008 |
| 69 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11193075 |
| 70 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10689117 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10182138 |
| 72 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.09582913 |
| 73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.09499450 |
| 74 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.08807991 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08752656 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08652054 |
| 77 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08341366 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07055603 |
| 79 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.06511489 |
| 80 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06490037 |
| 81 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.05829691 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04733449 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02190138 |
| 84 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01756952 |
| 85 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01715019 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01664427 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01652574 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01095214 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00768395 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00704999 |
| 91 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00243338 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00006711 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98881982 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98845538 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98455125 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98441416 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98217427 |
| 98 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98202514 |
| 99 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.97026486 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.96702738 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96663338 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95845885 |
| 103 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95523915 |
| 104 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94748065 |
| 105 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94747967 |
| 106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94457797 |
| 107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94295074 |
| 108 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93964684 |
| 109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93843617 |
| 110 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93482155 |
| 111 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93205614 |
| 112 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93077433 |
| 113 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92437032 |
| 114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91737157 |
| 115 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91705760 |
| 116 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91601234 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91577136 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91145156 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90050713 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89996028 |
| 121 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89449728 |
| 122 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89287093 |
| 123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88536460 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88294370 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 0.87660778 |
| 126 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87351480 |
| 127 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86895084 |
| 128 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86834864 |
| 129 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.86768838 |
| 130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86633817 |
| 131 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.86408338 |
| 132 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85840666 |
| 133 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85094733 |
| 134 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84576204 |
| 135 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84576204 |
| 136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83856109 |
| 137 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83771039 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83368636 |
| 139 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81674904 |
| 140 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80874403 |
| 141 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80810833 |
| 142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80798853 |
| 143 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80648876 |
| 144 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.79273825 |
| 145 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78917058 |
| 146 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75731231 |
| 147 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.74915375 |
| 148 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74852783 |
| 149 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.74811008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.01180634 |
| 2 | MP0001666_abnormal_nutrient_absorption | 3.60972926 |
| 3 | MP0001958_emphysema | 3.22825715 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.12693454 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.00938004 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.79491746 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75962184 |
| 8 | MP0004043_abnormal_pH_regulation | 2.64547978 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.64218756 |
| 10 | MP0005167_abnormal_blood-brain_barrier | 2.62297496 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.51085594 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.47806533 |
| 13 | MP0005409_darkened_coat_color | 2.43571341 |
| 14 | MP0009840_abnormal_foam_cell | 2.37907687 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.33522661 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.29331241 |
| 17 | MP0003252_abnormal_bile_duct | 2.23267277 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.14838245 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 2.05257130 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.00830834 |
| 21 | MP0001765_abnormal_ion_homeostasis | 1.99179880 |
| 22 | MP0004272_abnormal_basement_membrane | 1.97068809 |
| 23 | MP0000678_abnormal_parathyroid_gland | 1.94092513 |
| 24 | MP0001879_abnormal_lymphatic_vessel | 1.93932677 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 1.90727232 |
| 26 | MP0005275_abnormal_skin_tensile | 1.90217215 |
| 27 | MP0004782_abnormal_surfactant_physiolog | 1.89384722 |
| 28 | * MP0005410_abnormal_fertilization | 1.89330696 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.87378126 |
| 30 | MP0000537_abnormal_urethra_morphology | 1.76647885 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.69760151 |
| 32 | MP0000751_myopathy | 1.64098855 |
| 33 | * MP0009643_abnormal_urine_homeostasis | 1.61736935 |
| 34 | MP0000462_abnormal_digestive_system | 1.61036466 |
| 35 | MP0005451_abnormal_body_composition | 1.51906667 |
| 36 | MP0003879_abnormal_hair_cell | 1.51343623 |
| 37 | MP0006138_congestive_heart_failure | 1.48806809 |
| 38 | MP0000490_abnormal_crypts_of | 1.44735344 |
| 39 | MP0004084_abnormal_cardiac_muscle | 1.43289394 |
| 40 | MP0003866_abnormal_defecation | 1.43184439 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.43041540 |
| 42 | MP0003868_abnormal_feces_composition | 1.42377887 |
| 43 | MP0003303_peritoneal_inflammation | 1.41877460 |
| 44 | MP0000538_abnormal_urinary_bladder | 1.40971858 |
| 45 | MP0006054_spinal_hemorrhage | 1.39909985 |
| 46 | MP0002796_impaired_skin_barrier | 1.34575610 |
| 47 | MP0005377_hearing/vestibular/ear_phenot | 1.32388777 |
| 48 | MP0003878_abnormal_ear_physiology | 1.32388777 |
| 49 | MP0003045_fibrosis | 1.32196456 |
| 50 | MP0002822_catalepsy | 1.29602519 |
| 51 | * MP0005332_abnormal_amino_acid | 1.29067465 |
| 52 | MP0001188_hyperpigmentation | 1.23234654 |
| 53 | * MP0005166_decreased_susceptibility_to | 1.21671658 |
| 54 | * MP0002136_abnormal_kidney_physiology | 1.21353296 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.20691531 |
| 56 | MP0008961_abnormal_basal_metabolism | 1.19340928 |
| 57 | MP0005535_abnormal_body_temperature | 1.19160176 |
| 58 | MP0002971_abnormal_brown_adipose | 1.18430109 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 1.18311198 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.18015203 |
| 61 | MP0000477_abnormal_intestine_morphology | 1.17389227 |
| 62 | MP0006082_CNS_inflammation | 1.16019819 |
| 63 | * MP0001756_abnormal_urination | 1.14290589 |
| 64 | MP0009785_altered_susceptibility_to | 1.13747492 |
| 65 | MP0004147_increased_porphyrin_level | 1.13141540 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.12094586 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.11874853 |
| 68 | MP0001501_abnormal_sleep_pattern | 1.11789686 |
| 69 | MP0009115_abnormal_fat_cell | 1.11398578 |
| 70 | MP0003718_maternal_effect | 1.09861253 |
| 71 | MP0001664_abnormal_digestion | 1.09729701 |
| 72 | MP0004036_abnormal_muscle_relaxation | 1.06979568 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.06972043 |
| 74 | MP0003436_decreased_susceptibility_to | 1.06473505 |
| 75 | MP0003828_pulmonary_edema | 1.04299113 |
| 76 | MP0002295_abnormal_pulmonary_circulatio | 1.04220666 |
| 77 | MP0000604_amyloidosis | 1.02460325 |
| 78 | MP0001873_stomach_inflammation | 1.01342890 |
| 79 | MP0001835_abnormal_antigen_presentation | 0.99998936 |
| 80 | MP0004858_abnormal_nervous_system | 0.99126068 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 0.98064588 |
| 82 | * MP0001845_abnormal_inflammatory_respons | 0.97960093 |
| 83 | MP0005025_abnormal_response_to | 0.97488155 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 0.96855711 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.96546028 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 0.95983906 |
| 87 | MP0003950_abnormal_plasma_membrane | 0.95139017 |
| 88 | MP0002133_abnormal_respiratory_system | 0.94793522 |
| 89 | MP0005388_respiratory_system_phenotype | 0.94793522 |
| 90 | MP0000343_altered_response_to | 0.93554833 |
| 91 | MP0002254_reproductive_system_inflammat | 0.92400658 |
| 92 | MP0005330_cardiomyopathy | 0.91956640 |
| 93 | MP0008004_abnormal_stomach_pH | 0.91604980 |
| 94 | MP0005365_abnormal_bile_salt | 0.90845855 |
| 95 | MP0002089_abnormal_postnatal_growth/wei | 0.90642084 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.89228199 |
| 97 | MP0003724_increased_susceptibility_to | 0.88074065 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.87239133 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.86894434 |
| 100 | MP0005671_abnormal_response_to | 0.86405003 |
| 101 | MP0001790_abnormal_immune_system | 0.86169141 |
| 102 | MP0005387_immune_system_phenotype | 0.86169141 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.86140598 |
| 104 | * MP0008469_abnormal_protein_level | 0.85427374 |
| 105 | MP0004270_analgesia | 0.85415905 |
| 106 | MP0004130_abnormal_muscle_cell | 0.85169862 |
| 107 | MP0004484_altered_response_of | 0.84566058 |
| 108 | MP0010155_abnormal_intestine_physiology | 0.83475678 |
| 109 | MP0001663_abnormal_digestive_system | 0.83102537 |
| 110 | MP0002837_dystrophic_cardiac_calcinosis | 0.82883899 |
| 111 | MP0005670_abnormal_white_adipose | 0.82753998 |
| 112 | * MP0000249_abnormal_blood_vessel | 0.82653828 |
| 113 | * MP0000230_abnormal_systemic_arterial | 0.81693271 |
| 114 | MP0005165_increased_susceptibility_to | 0.80308457 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.79185204 |
| 116 | MP0003091_abnormal_cell_migration | 0.78063721 |
| 117 | MP0005023_abnormal_wound_healing | 0.76717341 |
| 118 | * MP0001544_abnormal_cardiovascular_syste | 0.76592680 |
| 119 | * MP0005385_cardiovascular_system_phenoty | 0.76592680 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.75703722 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.75645604 |
| 122 | MP0005310_abnormal_salivary_gland | 0.75103353 |
| 123 | MP0004947_skin_inflammation | 0.75054131 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.74521768 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.74205256 |
| 126 | MP0001849_ear_inflammation | 0.73994666 |
| 127 | MP0004087_abnormal_muscle_fiber | 0.73990606 |
| 128 | MP0003329_amyloid_beta_deposits | 0.73942407 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.73542572 |
| 130 | MP0002132_abnormal_respiratory_system | 0.72852167 |
| 131 | MP0002419_abnormal_innate_immunity | 0.71602796 |
| 132 | MP0000015_abnormal_ear_pigmentation | 0.70303877 |
| 133 | MP0002168_other_aberrant_phenotype | 0.70201035 |
| 134 | MP0002972_abnormal_cardiac_muscle | 0.70053254 |
| 135 | MP0005448_abnormal_energy_balance | 0.69230687 |
| 136 | MP0005164_abnormal_response_to | 0.68721469 |
| 137 | MP0000609_abnormal_liver_physiology | 0.67881029 |
| 138 | MP0004215_abnormal_myocardial_fiber | 0.67740021 |
| 139 | MP0000749_muscle_degeneration | 0.67554371 |
| 140 | MP0002896_abnormal_bone_mineralization | 0.67384768 |
| 141 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.67334687 |
| 142 | MP0003283_abnormal_digestive_organ | 0.66846483 |
| 143 | MP0002006_tumorigenesis | 0.66029326 |
| 144 | MP0003646_muscle_fatigue | 0.65799393 |
| 145 | MP0003172_abnormal_lysosome_physiology | 0.65612703 |
| 146 | * MP0009642_abnormal_blood_homeostasis | 0.63629681 |
| 147 | MP0000681_abnormal_thyroid_gland | 0.63032997 |
| 148 | MP0003075_altered_response_to | 0.62762785 |
| 149 | MP0000465_gastrointestinal_hemorrhage | 0.62556100 |
| 150 | * MP0001764_abnormal_homeostasis | 0.62168231 |
| 151 | MP0002098_abnormal_vibrissa_morphology | 0.60045413 |
| 152 | MP0009333_abnormal_splenocyte_physiolog | 0.59182450 |
| 153 | MP0005000_abnormal_immune_tolerance | 0.58044526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 5.24194651 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 5.09481343 |
| 3 | Chronic diarrhea (HP:0002028) | 4.83665076 |
| 4 | Polycythemia (HP:0001901) | 4.81888966 |
| 5 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.70049529 |
| 6 | Ileus (HP:0002595) | 4.38565955 |
| 7 | Abnormality of vitamin B metabolism (HP:0004340) | 4.36985627 |
| 8 | Confusion (HP:0001289) | 4.34420039 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 4.29373966 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.25470552 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 3.82492299 |
| 12 | Malnutrition (HP:0004395) | 3.82296234 |
| 13 | Hematochezia (HP:0002573) | 3.80897872 |
| 14 | Hydroxyprolinuria (HP:0003080) | 3.75474464 |
| 15 | Abnormality of proline metabolism (HP:0010907) | 3.75474464 |
| 16 | Abnormality of chloride homeostasis (HP:0011422) | 3.72292608 |
| 17 | Nausea (HP:0002018) | 3.66894436 |
| 18 | Chronic bronchitis (HP:0004469) | 3.48408692 |
| 19 | Abnormality of vitamin metabolism (HP:0100508) | 3.46678631 |
| 20 | Enlarged epiphyses (HP:0010580) | 3.44453076 |
| 21 | Interstitial pulmonary disease (HP:0006530) | 3.42039092 |
| 22 | Glycosuria (HP:0003076) | 3.39249551 |
| 23 | Abnormality of urine glucose concentration (HP:0011016) | 3.39249551 |
| 24 | Congenital sensorineural hearing impairment (HP:0008527) | 3.32645340 |
| 25 | Hyperglycinuria (HP:0003108) | 3.23962966 |
| 26 | Xanthomatosis (HP:0000991) | 3.20661290 |
| 27 | Decreased circulating renin level (HP:0003351) | 3.18910227 |
| 28 | Hypophosphatemia (HP:0002148) | 3.13518788 |
| 29 | Abnormality of the costochondral junction (HP:0000919) | 3.09880680 |
| 30 | Steatorrhea (HP:0002570) | 2.98779010 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 2.94399024 |
| 32 | Spontaneous hematomas (HP:0007420) | 2.90820616 |
| 33 | Increased connective tissue (HP:0009025) | 2.90659247 |
| 34 | Protuberant abdomen (HP:0001538) | 2.90147837 |
| 35 | Rectal prolapse (HP:0002035) | 2.89635040 |
| 36 | Aortic aneurysm (HP:0004942) | 2.88700449 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 2.86494475 |
| 38 | Delayed epiphyseal ossification (HP:0002663) | 2.84485837 |
| 39 | Hypokalemic alkalosis (HP:0001949) | 2.84477448 |
| 40 | Pigmentary retinal degeneration (HP:0001146) | 2.84151045 |
| 41 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.83444809 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.75789174 |
| 43 | Gout (HP:0001997) | 2.71938233 |
| 44 | Acanthocytosis (HP:0001927) | 2.71797962 |
| 45 | Esophageal varix (HP:0002040) | 2.68556025 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.68380325 |
| 47 | Hyperparathyroidism (HP:0000843) | 2.65684462 |
| 48 | Hyperaldosteronism (HP:0000859) | 2.65074955 |
| 49 | Visceral angiomatosis (HP:0100761) | 2.63540153 |
| 50 | Dehydration (HP:0001944) | 2.61094975 |
| 51 | Focal segmental glomerulosclerosis (HP:0000097) | 2.57425835 |
| 52 | Muscle fiber splitting (HP:0003555) | 2.56350659 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.54734609 |
| 54 | Gingivitis (HP:0000230) | 2.54584564 |
| 55 | Renal salt wasting (HP:0000127) | 2.54343097 |
| 56 | Megaloblastic anemia (HP:0001889) | 2.51403332 |
| 57 | Broad metatarsal (HP:0001783) | 2.50692149 |
| 58 | Glomerulonephritis (HP:0000099) | 2.48692942 |
| 59 | Abnormality of renin-angiotensin system (HP:0000847) | 2.48620102 |
| 60 | Hyperkalemia (HP:0002153) | 2.48268497 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.45111776 |
| 62 | Hyporeflexia of lower limbs (HP:0002600) | 2.43214571 |
| 63 | Nephrolithiasis (HP:0000787) | 2.40502071 |
| 64 | Hemangiomatosis (HP:0007461) | 2.39845097 |
| 65 | Posterior subcapsular cataract (HP:0007787) | 2.39008667 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.33056217 |
| 67 | Abnormal urine phosphate concentration (HP:0012599) | 2.32784866 |
| 68 | Alkalosis (HP:0001948) | 2.32526742 |
| 69 | Vascular calcification (HP:0004934) | 2.29153746 |
| 70 | * Widely patent fontanelles and sutures (HP:0004492) | 2.27885188 |
| 71 | Cerebral hemorrhage (HP:0001342) | 2.27860030 |
| 72 | Male infertility (HP:0003251) | 2.26338921 |
| 73 | Mesangial abnormality (HP:0001966) | 2.25710941 |
| 74 | Thin bony cortex (HP:0002753) | 2.24329082 |
| 75 | Increased purine levels (HP:0004368) | 2.22508842 |
| 76 | Hyperuricemia (HP:0002149) | 2.22508842 |
| 77 | Ventricular tachycardia (HP:0004756) | 2.20988057 |
| 78 | Abnormality of nucleobase metabolism (HP:0010932) | 2.20862696 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18494851 |
| 80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18494851 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18494851 |
| 82 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.17173015 |
| 83 | Cupped ribs (HP:0000887) | 2.17172306 |
| 84 | Metabolic alkalosis (HP:0200114) | 2.14328437 |
| 85 | Hypobetalipoproteinemia (HP:0003563) | 2.13553139 |
| 86 | Complement deficiency (HP:0004431) | 2.13459617 |
| 87 | Metaphyseal irregularity (HP:0003025) | 2.12615046 |
| 88 | Aneurysm (HP:0002617) | 2.12319251 |
| 89 | Abnormality of glycine metabolism (HP:0010895) | 2.12307958 |
| 90 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.12307958 |
| 91 | Aortic dissection (HP:0002647) | 2.11138816 |
| 92 | Tubulointerstitial fibrosis (HP:0005576) | 2.10696781 |
| 93 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.10131693 |
| 94 | Shawl scrotum (HP:0000049) | 2.09617164 |
| 95 | Nasal polyposis (HP:0100582) | 2.08360003 |
| 96 | Milia (HP:0001056) | 2.07031316 |
| 97 | Hyperphosphaturia (HP:0003109) | 2.06338851 |
| 98 | Bundle branch block (HP:0011710) | 2.05407731 |
| 99 | Abnormality of complement system (HP:0005339) | 2.05308949 |
| 100 | Hyperammonemia (HP:0001987) | 2.04225274 |
| 101 | Sudden death (HP:0001699) | 2.03103538 |
| 102 | Ketoacidosis (HP:0001993) | 2.02932311 |
| 103 | Abnormality of magnesium homeostasis (HP:0004921) | 2.01914472 |
| 104 | Atrophic scars (HP:0001075) | 2.00785869 |
| 105 | Villous atrophy (HP:0011473) | 2.00698645 |
| 106 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.00698645 |
| 107 | Axonal loss (HP:0003447) | 2.00482402 |
| 108 | Epidermoid cyst (HP:0200040) | 1.98143294 |
| 109 | Cerebral palsy (HP:0100021) | 1.97907105 |
| 110 | Hypomagnesemia (HP:0002917) | 1.95815048 |
| 111 | Long toe (HP:0010511) | 1.95721869 |
| 112 | Gastrointestinal dysmotility (HP:0002579) | 1.95314690 |
| 113 | Abnormality of macrophages (HP:0004311) | 1.94977868 |
| 114 | Hypoalbuminemia (HP:0003073) | 1.94535392 |
| 115 | Abnormal albumin level (HP:0012116) | 1.94535392 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 1.94530108 |
| 117 | Multiple lipomas (HP:0001012) | 1.94326385 |
| 118 | Pancreatitis (HP:0001733) | 1.93750728 |
| 119 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.92506483 |
| 120 | Abdominal distention (HP:0003270) | 1.92174590 |
| 121 | Hemorrhage of the eye (HP:0011885) | 1.91954873 |
| 122 | Increased circulating renin level (HP:0000848) | 1.91712346 |
| 123 | Abnormal glucose tolerance (HP:0001952) | 1.91202076 |
| 124 | Glomerulosclerosis (HP:0000096) | 1.91112480 |
| 125 | Proximal tubulopathy (HP:0000114) | 1.91089614 |
| 126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89365889 |
| 127 | * Abnormality of renal excretion (HP:0011036) | 1.89168033 |
| 128 | Subcapsular cataract (HP:0000523) | 1.88817660 |
| 129 | Syncope (HP:0001279) | 1.88512398 |
| 130 | Facial diplegia (HP:0001349) | 1.88068612 |
| 131 | Peripheral demyelination (HP:0011096) | 1.87703951 |
| 132 | Nephritis (HP:0000123) | 1.87376312 |
| 133 | Abnormality of potassium homeostasis (HP:0011042) | 1.85650822 |
| 134 | Lymphangioma (HP:0100764) | 1.84739377 |
| 135 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83065649 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.82581512 |
| 137 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82328655 |
| 138 | Abnormality of the gastric mucosa (HP:0004295) | 1.82306645 |
| 139 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.81921712 |
| 140 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81660006 |
| 141 | Hyperphosphatemia (HP:0002905) | 1.81082983 |
| 142 | Adrenal overactivity (HP:0002717) | 1.80461754 |
| 143 | Growth hormone excess (HP:0000845) | 1.79998890 |
| 144 | Fat malabsorption (HP:0002630) | 1.79786450 |
| 145 | Cavernous hemangioma (HP:0001048) | 1.79336640 |
| 146 | Ankle contracture (HP:0006466) | 1.78545385 |
| 147 | Hypokalemia (HP:0002900) | 1.77240324 |
| 148 | Difficulty running (HP:0009046) | 1.76814306 |
| 149 | Autoimmune hemolytic anemia (HP:0001890) | 1.76738971 |
| 150 | Tachypnea (HP:0002789) | 1.76186132 |
| 151 | Flat occiput (HP:0005469) | 1.76008638 |
| 152 | Bronchitis (HP:0012387) | 1.75282410 |
| 153 | Hypocalcemia (HP:0002901) | 1.75099909 |
| 154 | Bone cyst (HP:0012062) | 1.72994348 |
| 155 | Bone pain (HP:0002653) | 1.72855139 |
| 156 | Progressive sensorineural hearing impairment (HP:0000408) | 1.71934714 |
| 157 | Hand muscle atrophy (HP:0009130) | 1.71118288 |
| 158 | Irritability (HP:0000737) | 1.71113174 |
| 159 | Myoglobinuria (HP:0002913) | 1.71033414 |
| 160 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70774004 |
| 161 | Absent/shortened dynein arms (HP:0200106) | 1.70774004 |
| 162 | Increased cerebral lipofuscin (HP:0011813) | 1.70306783 |
| 163 | Loss of speech (HP:0002371) | 1.70241820 |
| 164 | Skin nodule (HP:0200036) | 1.69237954 |
| 165 | Petechiae (HP:0000967) | 1.68428324 |
| 166 | Hypolipoproteinemia (HP:0010981) | 1.68239483 |
| 167 | Metabolic acidosis (HP:0001942) | 1.66824528 |
| 168 | Stroke (HP:0001297) | 1.65192258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.08858136 |
| 2 | TIE1 | 4.07897352 |
| 3 | FRK | 3.37128015 |
| 4 | MST4 | 3.31718156 |
| 5 | ERN1 | 3.21225422 |
| 6 | LMTK2 | 3.07090147 |
| 7 | AKT3 | 3.01751072 |
| 8 | RIPK1 | 2.67910481 |
| 9 | PDK4 | 2.52481942 |
| 10 | PDK3 | 2.52481942 |
| 11 | TGFBR2 | 2.42193590 |
| 12 | PDK2 | 2.32207348 |
| 13 | MST1R | 2.06711070 |
| 14 | MYLK | 2.01800159 |
| 15 | TESK1 | 2.01194778 |
| 16 | WNK4 | 1.98869279 |
| 17 | PTK6 | 1.98397178 |
| 18 | TESK2 | 1.90338196 |
| 19 | TRIB3 | 1.86417212 |
| 20 | EPHB1 | 1.78733536 |
| 21 | EPHB2 | 1.70822168 |
| 22 | RIPK4 | 1.68087001 |
| 23 | TTN | 1.67895879 |
| 24 | EPHA2 | 1.66905054 |
| 25 | LATS1 | 1.66422496 |
| 26 | MAP3K2 | 1.60550098 |
| 27 | PRKD3 | 1.58977824 |
| 28 | MAP4K1 | 1.55964107 |
| 29 | ICK | 1.52972851 |
| 30 | MAP3K11 | 1.52448076 |
| 31 | PRKG2 | 1.51073491 |
| 32 | STK39 | 1.47877109 |
| 33 | FER | 1.44840189 |
| 34 | LRRK2 | 1.40414159 |
| 35 | STK10 | 1.35878199 |
| 36 | PDGFRA | 1.35388440 |
| 37 | DMPK | 1.32850700 |
| 38 | CDC42BPA | 1.28369031 |
| 39 | PRPF4B | 1.19486657 |
| 40 | BLK | 1.17208488 |
| 41 | GRK6 | 1.16040689 |
| 42 | TAOK3 | 1.14041447 |
| 43 | PAK4 | 1.11560577 |
| 44 | OXSR1 | 1.09112774 |
| 45 | PTK2B | 1.08602666 |
| 46 | NME1 | 1.07032507 |
| 47 | DDR2 | 1.06812849 |
| 48 | MAP2K2 | 0.96387834 |
| 49 | MET | 0.96289293 |
| 50 | MAP3K3 | 0.96158320 |
| 51 | PDPK1 | 0.95046441 |
| 52 | MAP2K6 | 0.92600127 |
| 53 | MAP3K7 | 0.92540838 |
| 54 | FGFR4 | 0.89506309 |
| 55 | WNK3 | 0.89221497 |
| 56 | PTK2 | 0.86337001 |
| 57 | MAP3K10 | 0.85469953 |
| 58 | SIK1 | 0.83005322 |
| 59 | IRAK3 | 0.82740020 |
| 60 | RPS6KA2 | 0.79410180 |
| 61 | KDR | 0.78633219 |
| 62 | TNIK | 0.76279826 |
| 63 | EEF2K | 0.75675653 |
| 64 | GRK1 | 0.75663552 |
| 65 | CAMK1G | 0.73496580 |
| 66 | STK38 | 0.73364553 |
| 67 | PKN2 | 0.71416417 |
| 68 | ABL2 | 0.70940713 |
| 69 | CSK | 0.70802057 |
| 70 | BMX | 0.70800480 |
| 71 | DAPK2 | 0.70337986 |
| 72 | NUAK1 | 0.69293787 |
| 73 | ERBB2 | 0.67111700 |
| 74 | BCKDK | 0.66430506 |
| 75 | ADRBK2 | 0.66325441 |
| 76 | ZAP70 | 0.65977347 |
| 77 | CAMK1D | 0.65794721 |
| 78 | MAP3K14 | 0.64251701 |
| 79 | MAPK11 | 0.63937858 |
| 80 | PDGFRB | 0.63844945 |
| 81 | JAK3 | 0.63773073 |
| 82 | PDK1 | 0.63741316 |
| 83 | EPHA4 | 0.63532191 |
| 84 | PRKD1 | 0.63072080 |
| 85 | CSF1R | 0.62314173 |
| 86 | PHKG1 | 0.62104013 |
| 87 | PHKG2 | 0.62104013 |
| 88 | MAPKAPK3 | 0.61350179 |
| 89 | TAOK1 | 0.61030321 |
| 90 | MATK | 0.59749273 |
| 91 | PRKAA2 | 0.59411189 |
| 92 | KSR2 | 0.58386206 |
| 93 | PRKACG | 0.58339564 |
| 94 | FGFR2 | 0.56857117 |
| 95 | TGFBR1 | 0.56215167 |
| 96 | PAK2 | 0.53111083 |
| 97 | WNK1 | 0.53098289 |
| 98 | MAP3K1 | 0.52923879 |
| 99 | PLK4 | 0.52877235 |
| 100 | ROCK1 | 0.52201333 |
| 101 | PRKCZ | 0.51055749 |
| 102 | FGFR3 | 0.51039181 |
| 103 | PRKCA | 0.50886154 |
| 104 | MAP2K3 | 0.50226475 |
| 105 | STK3 | 0.49557165 |
| 106 | GRK7 | 0.49108645 |
| 107 | DYRK1B | 0.48726260 |
| 108 | GSK3A | 0.48215426 |
| 109 | MAPK15 | 0.47930900 |
| 110 | PRKAA1 | 0.47784921 |
| 111 | TBK1 | 0.47478403 |
| 112 | RET | 0.46562266 |
| 113 | KIT | 0.45020711 |
| 114 | ITK | 0.44761943 |
| 115 | NLK | 0.44224382 |
| 116 | IRAK1 | 0.42552844 |
| 117 | RPS6KL1 | 0.42366085 |
| 118 | RPS6KC1 | 0.42366085 |
| 119 | MAP3K12 | 0.41726295 |
| 120 | SYK | 0.41429855 |
| 121 | STK38L | 0.41379424 |
| 122 | JAK1 | 0.40396158 |
| 123 | IKBKE | 0.40348928 |
| 124 | PIK3CA | 0.40101542 |
| 125 | PIK3CG | 0.39759406 |
| 126 | PRKCH | 0.38828377 |
| 127 | INSRR | 0.37961281 |
| 128 | TYRO3 | 0.37543903 |
| 129 | FYN | 0.37344797 |
| 130 | PIM2 | 0.37183160 |
| 131 | JAK2 | 0.37161347 |
| 132 | SCYL2 | 0.35922588 |
| 133 | RPS6KA6 | 0.35763588 |
| 134 | EPHA3 | 0.35433351 |
| 135 | TYK2 | 0.34619981 |
| 136 | NEK6 | 0.34572340 |
| 137 | MAPK7 | 0.34500886 |
| 138 | PIM1 | 0.34004490 |
| 139 | SGK3 | 0.33585507 |
| 140 | LYN | 0.33493993 |
| 141 | MTOR | 0.32053591 |
| 142 | PRKCD | 0.31472976 |
| 143 | CAMK2D | 0.31459649 |
| 144 | PAK3 | 0.31409827 |
| 145 | SRC | 0.30716854 |
| 146 | BTK | 0.29868934 |
| 147 | EGFR | 0.29792219 |
| 148 | CAMK2G | 0.29225721 |
| 149 | LCK | 0.28901665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.88018655 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.95199758 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.89885284 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 2.86853663 |
| 5 | * Renin-angiotensin system_Homo sapiens_hsa04614 | 2.64209633 |
| 6 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.56051318 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.53183517 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.51669307 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.40700008 |
| 10 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.00161423 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 1.93319493 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.88974589 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.78766437 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77540647 |
| 15 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.63425828 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63168896 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62686027 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.58529352 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.57779016 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51688441 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48656764 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.48654432 |
| 23 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47265902 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.38928470 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36331291 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36233193 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.34872225 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34646651 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.33692996 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30407551 |
| 31 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.30038633 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25965788 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.23253938 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.22876388 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20220023 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19332161 |
| 37 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.19216120 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17837524 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.16031390 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12287655 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.08959773 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08266261 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.04882019 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04255094 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 1.04080762 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 0.97861999 |
| 47 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.97738953 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97559594 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95030391 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93517326 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93275868 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92816817 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92472717 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92103998 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92039345 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91270534 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.90382484 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90218062 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88678137 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85634959 |
| 61 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85375716 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84399903 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79670254 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78767603 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.77819543 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72196288 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.71875021 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70637915 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70556677 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.70445140 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.69560268 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68290522 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67753557 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67393180 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65814780 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65688027 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65633378 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64002387 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63862807 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63627309 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61584472 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56154663 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.55570270 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54746785 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54741075 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53936562 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52931220 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.52896190 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.52684002 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.50633421 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50106977 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47632019 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47596947 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46688648 |
| 95 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46600866 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46333153 |
| 97 | * Renin secretion_Homo sapiens_hsa04924 | 0.46317697 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45020935 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.44458217 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42828543 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42561726 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41826620 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41548337 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41528642 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40938862 |
| 106 | Tuberculosis_Homo sapiens_hsa05152 | 0.39756933 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.39500041 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38792565 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38508947 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38056985 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37720258 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37492746 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37105729 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35925414 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.35715472 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35661770 |
| 117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34604165 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.34482433 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34331047 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32034760 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31683393 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31682669 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31585911 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31115816 |
| 125 | Gap junction_Homo sapiens_hsa04540 | 0.30075952 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.29754511 |
| 127 | Insulin secretion_Homo sapiens_hsa04911 | 0.28702158 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28382834 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.28188211 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.26264330 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25020092 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.24676862 |
| 133 | Influenza A_Homo sapiens_hsa05164 | 0.22969170 |
| 134 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.22169967 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.20293067 |
| 136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.20126093 |
| 137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19290385 |
| 138 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19208983 |
| 139 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.19152693 |
| 140 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18643021 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18411610 |
| 142 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.16705517 |
| 143 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13245240 |
| 144 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.10749378 |

